throbber
MYR 1030
`Myriad Genetics, Inc. et al. (Petitioners) v. The Johns Hopkins University (Patent Owner)
`IPR For USPN 7,824,889
`
`Page 1 of 30
`
`

`

`Oxford University Press, Walton Street, Oxford OX2 GDP
`New York
`and Bangkok Bombay
`Athens A
`Town Dor es Salaam Delhi
`Calcutta
`Cape
`ngKong Istanbul Karachi
`Florence
`dras Modrid Melbourne
`Kuala caeeee
`Mexico City Nairobi Paris Singapore
`Taipei Tokyo Toronto
`and associated companies in
`Berlin Ibadan
`
`Oxford is a trade mark of Oxford University Press
`
`Published in the United States
`by Oxford University Press Inc., New York
`
`© Oxford University Press, 1995
`
`All rights reserved. No part of this publication may be
`reproduced, stored in a retrieval system, or transmitted. in any
`— or by any means, without the prior permission in writing of raren
`Press. Within the UK, exceptions are allowed in respect of any
`ini
`fair dealing for the purposeofresearch or private study, or criticism or
`review, as permitted under the
`ight, Designs and Patents Act. 19688. or
`phic reproduction in accordance with the terms of
`in the case of re
`licences issued by
`Gopyright Licensing Agency. Enquiries concerning
`reproduction outside those terms and in other countries should be sent to
`the Rights Department, Oxford University Press, at the address above.
`
`This book is sold subject to the condition that it shall not,
`by way of
`trade or otherwise, be lent, re-sold, hired out, or otherwise
`circulated without the publisher's
`consent in any form of binding
`or cover other than that in which it is published and without a similar
`condition including this condition being imposed
`on the
`ent purchaser.
`
`Users of books in the Practical Approach Series are advised that
`prudent
`laboratoryaapnypiven shoadd befollowed at all times.
`the accurocy of the material set forth iY tas cs dle tater end comet”
`no representation. express or implied, in respect o
`University Press
`SOAPE ERY OOMaae ay for any errors or om
`A catalogue record for this book is available from the British Library
`
`i
`
`liabil
`
`issions
`
`Library of Congress Cataloging-in-Publication Data
`
`1. HIV in
`
`=
`
`-
`
`*
`
`+
`
`idee
`
`ruses) —
`
`(Viruses)
`‘seth
`“al
`fections
`2 HIV Infections
`1 “HIV. isolation earn :
`.
`4. HIV Seropositivity.
`virology. "3. HIV Infections — imam:
`5. Antiviral Agents.
`6. ae niques.
`QW168.5.H6
`H6761995
`616.97°9201—dc20
`
`QA201.A37H55 1995
`
`§5—15495
`
`ISBN 0 19 963493 9 (v. 1 : Hbk]
`ISHN 0 19 963492 O [v. 1 : Pbk)
`ISBN 0 19 963499 8 (v. 2: Hbk)
`ISBN 0 19 963498 X (v. 2 : Pbk)
`ISBN @ 19 963501 3 (set: Hbk)
`ISBN 0 19 963500 5 (set: Pbk)
`
`by Footnote Graphics, Warminster, Wilts
`Printed in Great Britain by Information Press Ltd, Eynaham, Oxon,
`
`Page 2 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 2 of 30
`
`

`

`Sequence analysis of virus
`variability based on the poymerase
`chain reaction (PCR)
`
`ANDREW J. LEIGH BROWN and PETER SIMMONDS
`
`1. Introduction
`
`During most stages of HIV infection, the viral population contains a large
`number of closely related variants that have diverged within the indvidual
`over the course of HIV infection. For example, env sequences of human
`immunodeficiency virus in lymphocytes of infected individuals may show
`variability of up to 10% within the same sample (1, 2). Under these circum-
`stances, sequence analysis of PCR products amplified from such samples is
`often unreliable due to ambiguities in the sequencing gel. While there are
`methods for measuring the relative frequencies of alternative nucleotides at
`these polymorphic sites (see section 3), this does not distinguish the linkage
`relationships of the variant nucleotides so it is impossible reliably to recon-
`struct the constituent sequences.
`An even more serious problem is encountered when attempts are made to
`read a ‘consensus’ sequence in areas of the HIV genome where sequences
`differ from each by the presence ofinsertions or deletions of nucleotides(e.g.
`the V1, V2, V4, and V5 hypervariable regions of the env gene). The presence
`of variants that differ in length make a consensus sequence completely un-
`readable downstream of the position of the point of the deletion/insertion.
`On the other hand,
`the presence of length variants allow different viral
`populations to be rapidly compared, by amplification of a sample of the virus
`population across the hypervariable regions (3). Methods for analysing the
`length profiles of whole virus populations in vivo are described in section 3.
`
`2. Amplification of viral sequences
`2.1 Limiting dilution assays
`There are two methods for isolating single viral sequences to enable the
`analysis of heterogeneous samples. In the first method, cDNA orproviral
`DNAis amplified by the PCR followed by cloning of the PCR productinto
`
`Page 3 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 3 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`a plasmid (e.g. pUC) or bacteriophage (e.g. M13) vector. Sequencing can
`then be carried out on individual clones isolated by plating out the libraryin
`E. coli. Most of the problems encountered with this technique are associated
`with inserting blunt, non-phosphorylated DNA into a vector, and inaccuracies
`within the nucleotide sequences that are inevitably introduced by the amplifi-
`cation and cloning of viral sequences with certain DNA polymerases (sce
`section 2).
`These difficulties led us to develop an alternative method for obtaining
`single sequences from a heterogeneous sample, in which proviral DNA or
`cDNA present in a sample is diluted sufficiently prior to amplification to
`ensure that only single target sequences are amplified in each reaction. To
`separate the sequences,it is necessary to amplify DNA in multiple replicates
`at a dilution where only a small proportion of the reactions yield amplified
`DNA. Asthedistribution of very dilute DNA between tubes by macroscopic
`pipetting is a random stochastic process, the Poisson formula can be used to
`calculate the likelihood of positive tubes having originally contained one, or
`more than one molecules of target DNA (Table /). When the frequency of
`PCR-positive reactions is 0.2, approximately 95% of reactions can be pre-
`dicted to have originated from single target sequences, whereas only half
`of reactions will be derived from single sequences when the frequency of
`positives is 0.7.
`This method of separation is critically dependent on the reliable detection
`
`Table 1. Quantitation and separation of sequences by limiting dilution
`
`Observed
`frequency positives
`
`Calculated number
`DNA sequences”
`
`Proportion single
`copies”
`
`0.001
`0.01
`0.05
`0.10
`0.15
`0.20
`0.25
`0.30
`0.40
`0.50
`0.60
`0.70
`0.80
`0.90
`0.95
`
`0.001
`0.010
`0.051
`0.105
`0.163
`0.223
`0.288
`0.357
`0.511
`0.693
`0.916
`1.204
`1.609
`2.302
`2.996
`
`99.9%
`99.5%
`97.5%
`94.8%
`92.1%
`89.3%
`86.3%
`83.2%
`76.6%
`69.3%
`61.1%
`51.2%
`40.2%
`25.6%
`15.8%
`
`* Actual frequency, f (in target molecules/replicate tube) calculated according to
`the formula f = — In (f°), where (FP) is the observed frequency of negative
`reactions.
`® Proportion of positive replicates, f derived from a single copy of target DNA.
`
`162
`
`Page 4 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 4 of 30
`
`

`

`11; Sequence analysis of virus variability based on PCR
`
`of single molecules of the appropriate HTV sequence, While it is possible to
`detect positive reactions by hybridization of the PCR with a probe of high
`specific activity (4), the maximum sensitivity of such methods is generally
`around 3—100 copies of template DNA (5-7). We use the more sensitive
`nested PCR approach (Protocol /). A nested PCR can produce sufficient
`amounts of DNA from a single template molecule for sequence analysis. For
`example, a 300 bp target sequence has a molecular weight of 10000 g/mol
`and a mass of 0.016 ag (1 ag = 10~'* g); amplification by a factor of 10’ with
`outer primers, and 10° with inner primers would produce 160 ng of PCR
`product. In contrast, a single amplification of one copy of target DNA by as
`much as 10°-fold would produce barely enough product to be detectable by
`the most sensitive hybridization techniques (1.6 pg DNA).
`
`Protocol 1. Amplification of DNA by nested PCR
`
`
`
`Equipment and reagents
`« PCR buffer: 200 mM Tris-HCI pH 8.8, 500
`mM KCl, 15 mM MgCl,, 0.5% Triton X-100
`« Nucleotide triphosphates (100 = stock): 3
`dTTe
`mM each of dATP, dCTP. dGTP,
`15—60 pM sense primer (for a 20-mer, 100—
`400 pg/ml)
`15—60 pM antisense primer
`Mineral oi] (BDH, Cat. No. 279436)
`Taq polymerase (Cetus, Promega, North-
`umbria, Boehringer)
`Programmable thermal cycler
`Protective goggles, or (preferably) full face
`mask
`
`ned
`1.5% oegarose” gel in 1 = TBE,
`with 0.66 pg/ml ethidium bromide (note:
`ethidium bromide is highly mutagenic,
`always wear gloves when handling gels or
`solutions)
`1 = TBE electrophoresis buffer, containing
`0.66 pg/ml ethidium bromide
`size of
`Size markers spanning
`second PCR product (e.g. plasmid DNA,
`such as pBA322 digested with Haelll,
`Boehringer Cat. No. 821705)
`« Ultraviolet light box
`
`Method
`
`1. For each sample, pre-mix:
`e 5 pl PCR buffer
`38 yl water
`0.5 wl nucleotide triphosphates
`0.25 wl sense primer (approx. 4—16 pmol)
`0.25 pl antisense primer
`1 U Taq polymerase (0.1—0.25 pl at most manufacturers’ supplied
`concentrations)
`e 5 »!l DNA or cDNA sample (diluted, if appropriate)
`For amplifying multiple samples,it is easier to make up a stock contain-
`ing all but the sample, and adding 45 I to each tube. Cover with a drop
`of mineral oil.
`
`2. Transfer immediately to a thermal cycler set with the following temper-
`atures and times: 94°C 35 sec; 50°C 40 sec; 68°C 150 sec.
`
`163
`
`Page 5 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 5 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`Protocol 1. Continued
`
`3. Samples should be amplified over 25—35 cycles (25 cycles is sufficient
`with outer and inner primers in nested PCR protocols).
`
`4. The samples should be heated at 68—72°C for 5 min at the end of the
`last cycle to terminate uncompleted strands.
`
`5. Amplified DNA is stable, and can be stored at 4°C (or at —20°C long-
`term) before carrying out the second amplification reaction or cloning.
`
`6. For each reaction, prepare 20 ul reaction buffer containing:
`2 p! PCR buffer
`17.7 wl water
`0.1 wl! of a 0.01 pg/ml orange G dye solution in water
`0.2 yl nucleotide triphosphates
`0.1 yw! inner sense primer (1.5—6 pmol, biotinylated)
`0.1 pl inner antisense primer (20 pmol, not biotinylated)
`0.4 U Taq polymerase (0.05—0.2 1)
`1 wl” of amplified DNA from step 5
`Cover with a drop of mineraloil.
`
`7. Transfer to a thermal cycler set with the times, temperatures, and
`numbers of cycles as for first PCR (steps 1—5).
`
`8. After amplification, analyse entire sample by agarose gel electro-
`phoresis, along with size markers. View on ultraviolet box. Bands
`ranging in size from 500—100 bp will be resolved adequately by this
`procedure.
`
`of the PCR.
`
`*High concentrations of agarose impair the transparency of the gel. Low melting point
`agarose produces clearer gels, but is more expensive, and not necessary unless gels are to be
`photographed.
`“Most laboratory workers experience the urge to add more than 1 pl to the second PCR
`reaction. In fact, this amount is more than adequate; addition of larger amounts will load to
`the appearance of multiple non-specific bands in the product, which can reduce the sensitivity
`
`To demonstrate the detection of single molecules of target DNA, serial
`tenfold dilutions of a cloned HIV sequence (pBH10.R3) were amplified with
`conserved gag-specific primers as described in Protocol | (Figures 1A and
`1B). While 65 fg of target DNA yielded a visible band after the first round
`of amplification (lane 3), as little as 6.5 ag (10~'* g) produced a positive signal
`after the second round (lane 7). The negative control that contained 1 pg
`herring sperm DNA was completely negative after the second round of
`amplification (lane 9). The mass of one molecule of the target DNA used in
`this titration (pBH10.R3) was 13 ag, thus the amount detected at the final
`dilution may have been as little as one molecule. We can also show that
`dilution separates single molecules of target sequence by amplifying replicate
`
`164
`
`Page 6 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 6 of 30
`
`

`

`11: Sequence analysis of virus variability based on PCR
`
`]
`
`2
`
`3
`
`4
`
`5
`
`6
`
`/
`
`8
`
`9
`
`10
`
`1
`
`$2
`
`3S
`
`ee Bee eee. BO)
`
`Se
`
`ae
`
`
`
`Figure 1. Titration of viral DNA sequences by nested PCR (reproduced with permission
`from the American Society for Microbiology). Dilution series of recombinant H!IV-1 DNA
`amplified by outer gag primers (A), followed by amplification of 1 wl! of product with inner
`gag primers (B). Lanes 1—8: tenfold dilutions of pBH10.R3 in 200 pg/ml herring sperm
`DNA from 6.5 pg in lane 1 (5 =x 10° copies target sequence) to 0.65 ag in lane 8 (nominally
`0.05 copies); lane 9: negative contro! (herring sperm DNA; lane 10: size markers (pTZ18R,
`digested with Haelll). Note:
`1 ag = 10~“* g. Addition of 65 fg (5000 copies) produces a
`faint band after the first PCR (lane 3), while 6.5 ag (nominally 0.5 copies) produces a band
`after the second PCR (lane 7). C. Limiting dilution: amplification of replicate samples each
`nominally containing 0.5 molecules of target HIV-1 sequence with nested gag primers (6.5
`ag amounts of pBH10.A3; lanes 2—12). Lane 1: negative control (1 wg herring sperm DONA);
`lane 13: positive contro! (65 ag pBH10.R3); lane 14: molecular size markers. See Tab/e 1
`for frequencies of positives at other input HIV DNA concentrations.
`
`samples containing different nominal amounts of target sequence, and analysing
`the products by agarose gel electrophoresis (Figure /C, and ref. 8). Multiple
`replicates of 6.5 ag amounts of target DNA yielded somepositivesignals and
`some negatives. Their frequency varied with the amount of target DNA
`amplified (8).
`
`165
`
`Page 7 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 7 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`These experiments were carried out using recombinant DNA astarget.
`However, the method can be readily used for separation of viral sequences
`present in vivo. In order to ensure that the target viral sequences are dis-
`tributed randomly on dilution, it is usually necessary to shear DNA samples
`by ultrasonication or cleavage with a restriction enzyme that cleaves at rare
`sites (e.g. Sfil, Notl, that do not cleave HIV DNA). Separation of viral RNA
`sequences can be achieved by limiting dilution of the cDNA synthesized from
`it, as it is less likely to degrade on storage than RNA (9, 10).
`
`2.2 Solid phase purification of PCR product
`Sequencing using the Sanger method requires strand extension from a primer;
`this can be one of the primers used previously in the PCR, or it can corre-
`spond to sequenceswithin the amplified fragment. The sequencing reactionis
`highly sensitive to nucleotide triphosphates, primers, and buffer components
`present in the PCR product, thusit is necessary to purify the amplified DNA
`prior to carrying out the strand extension and termination reactions (11).
`Wehave adopted a single-strand purification procedure in which the PCR
`is carried out with a biotinylated primer in the second reaction (Protocol 2).
`Purification of the template in this way has a number of advantages.
`In
`particular, as there is a virtual absence of strong stops, strand extension takes
`place more readily and thus more of the sequence is readable. Less product
`DNAfrom the PCR is required to produce a strong signal in the sequencing
`gel, and the extraction of low molecular weight DNA attached to a solid
`phase is quicker and moreefficient than those based upon bonding to glass
`milk or ethanol precipitation. Finally, there are no problems with primercarry
`over; unreacted biotinylated primer remains attachedto the solid phase during
`the sequencing reaction, and can not cause inappropriate strand extension.
`
`Protocol 2. Purification of single-stranded amplified DNA on
`magnetic beads
`
`« 06.15 M sodium hydroxide (NaOH) solution
`
`Equipment and reagents
`« Extraction buffer: 10 mM Tris—HC! pH 7.5,
`1 mM EDTA, 2.0 M NaCi
`« Dynabeads coated with streptavidin
`® TE buffer: 10 mM Tris—HCi pH 8.0,
`EDTA
`
`1 mM
`
`« Magnet (e.g. Dynal MPC-E (Product No.
`120.04) for 1.5 ml Eppendorf tubes; Dynal
`MPC-96 (Product No. 120.05) for microtitre
`plates)
`
`A. Manual sequencing
`1. Amplify viral sequence(s) by nested PCR and one biotinylated (inner)
`primer (Protoco/ 1). Use a 50 yp! volume of PCR buffer for the second
`PCR.
`2. Resuspend dynabeads gently. For each sample to be sequenced, pipette
`10 wl into a 1.5 ml Eppendorf tube or into a well of a microtitre plate.
`
`166
`
`Page 8 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 8 of 30
`
`

`

`11: Sequence analysis of virus variability based on PCR
`
`Pre-wash in 40 ul 0.1% bovine serum albumin (caution: do not spin
`dynabeads during washing).
`3. Resuspend beads in 40 y! extraction buffer. Add 40 yl PCR product.
`Mix well, incubate at room temperature for 20 min, resuspending oc-
`casionally.
`4. Wash beads in 40 yw! extraction buffer; resuspend in 8 yp! 0.15 M NaOH.
`incubate at room temperature for 10 min.
`5. Remove supernatant (this contains unbound complementary sense
`DNA, and can also be sequenced (step 8)).
`6. Wash beads once with 50 »! NaOH, once with 50 yl extraction buffer,
`and once with 50 y! TE buffer.
`7. Resuspend beads in 20 yl TE buffer. Proceed to step 9.
`8.
`If required, neutralize unbound (complementary sense) DNA eluted
`from dynabeads by addition of 4 p! 0.3 M HC! and 1 pl 1M Tris—HCI
`pH 7.5 Make up to 20 pl with water.
`
`. Automatic sequencing (ABI 373A)
`
`. As above.
`Resuspend dynabeads gently. For each sample, pipette 20 pI! into a
`0.5 ml Eppendorf tube. Pre-wash in 40 yl extraction buffer.
`. Resuspend beadsin 40 yp! extraction buffer. Add 40—100 pl PCR prod-
`uct, according to concentration. Mix well, incubate at 48°C for 30 min.
`. Wash beadsin 40 pl extraction buffer; resuspend in 8 yl 0.1 M NaOH.
`Incubate at room temperature for 10 min.
`
`. As above.
`. As above but with 0.1 M NaOH.
`
`with water.
`
`. As above but in 14 yl sterile distilled water.
`. Neutralize complementary sense DNA eluted from dynabeads by addi-
`tion of 4 wl 0.2 M HCI and 1 pl 1 M Tris—HCI pH 7.5. Make up to 14 pl
`
`A potential problem with this technique is the limited binding capacity of
`the streptavidin bound to the solid phase, and it is essential that relatively
`low concentrations of biotinylated primers are used in the second PCR. We
`have found it important, especially for automated sequencing,to titrate the
`primers to find the minimum amountthat can be used reliably in the limiting
`dilution technique. For the V3 primers described in ref. 2, 6 pmol of sense
`and antisense primers have been used successfully in the second PCR for
`manual sequencing. For automated sequencing with T7 DNA polymerase,
`we use 5 pmol biotinylated and 10 pmol non-biotinylated primers.
`In most circumstances,it is desirable to sequence DNA from both ends of
`
`167
`
`Page 9 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 9 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`the amplified fragment. This can be achieved either by carrying out two
`second PCR amplifications (with sense and antisense biotinylated primers) or
`by purifying both the bound and the unbound strand. These products are
`then separately extracted and sequenced from the opposite end with the other
`primer. To sequence the opposite strand the complementary single-stranded
`DNA is eluted from the solid phase after denaturation of the bound PCR
`product with sodium hydroxide (steps 5, 8). The eluate is neutralized by
`addition of an equimolar amount of HCI and Tris-HCl! buffer, adjusted to a
`final 20 wl volume, and sequenced in solution (steps 9 onwards).
`
`3. Sequencing PCR-amplified products
`3.1 Manual sequencing
`In the sequencing reaction for manual gels, the single-stranded DNA ts
`annealed to the sequencing primer; strand synthesis takes place initially in
`the presence of cold dGTP, dCTP, dTTP, and a limiting concentration of
`radiolabelled dATP, followed by a five minute incubation in the presence of
`each dideoxynucleotide for the termination reaction. The partial transcripts
`formed in each of the four termination reactions (i.e. with ddGTP, ddATP,
`ddTTP, and ddCTP) are separated by electrophoresis on a high-resolution
`denaturing (single-stranded) gel to allow the nucleotide sequence to be read.
`Single-stranded sequencing reactions are readable from around 10—20 bp
`downstream of the 3’ base of the sequencing primers, to around 350 bp using
`the BRL gel apparatus.
`
`3.2 Automated sequencing with dye-labelled
`terminators
`
`the approach
`Although also based on the Sanger sequencing procedure,
`involved in automated sequencing with dye terminators differs in some tm-
`portant respects. The four terminating dideoxynucleotides are labelled with
`a dye molecule (Protocols 3 and 4) each of which emits light at a different
`wavelength when excited by the laser which continually scans the gel while
`it is running. In consequence, the products of each reaction may be loaded
`in the same track, enabling 24 (or 36) reactions to be run on one gel. The
`scanning window, for excitation and detection of fluorescence is very small
`and each molecule being recorded only remains within the window for a very
`short time. Each reaction must havea similar intensity of signal. Consequently
`the yields from the template preparation steps must be carefully optimized
`for successful sequencing. The requirement
`is particularly important for
`sequencing with T7 DNA polymerase (‘Sequenase’). On the other hand, the
`gel products are continually scanned and a much longer read can be obtained
`as they are all being detected towards the bottom of the gel. Thus accurate
`sequencing is possible up to 450 bp and even longer fragments can be read if
`a lower level of accuracy can be tolerated. One major advantage of the dye-
`
`168
`
`Page 10 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 10 of 30
`
`

`

`11: Sequence analysis of virus variability based on PCR
`
`terminator method is the absence of ‘strong-stop’ artefacts, since any prema-
`turely terminated molecule will not have incorporated a labelled molecule,
`in contrast to manual Sanger sequencing.
`
`Protocol 3. Single-stranded DNA sequencing using the ABI 373A
`automatic sequencer and T7 DNA polymerase with
`dye-labelled terminators
`
`they are, to our
`
`knowledge, the only
`
`sup-
`
`Soph
`
`DNA template for six control reactions.
`
`Equipment and reagents
`* Materials for sequencing reactions are best
`« 8M ammonium acetate, filtered before use
`obtained from Applied Biosystems in the
`through a 0.2 um fitter
`PRISM Sequenase Terminator Single-
`« Formamide/EDTA
`(5:1):
`yaaaey DNA Semone ae At oe formamide/50 mM EDTA pH 8.0
`pliers of dye-labelled terminators for use
`* EYecermiinstorwash buffer: 0.01 M Tris pH
`with T7 DNA polymerase.
`The kits (enough for 150 reactions) comprise:
`—600 pl Sequenase dye terminator mix
`{a-thio dNTPs)
`—1.0 ml MOPS buffer pH 7.5: 0.4M MOPS
`pH 7.5, 0.6 M NaCl, 0.1 M MgCls, 25%
`glycerol
`—1,0 ml Mn?*/isocitrate solution: 50 mM
`MnCl,, 0.15 M isocitrate, 25% glycerol
`—160 pl Sequenase (1.35 U/l)
`together with primer and single-stranded
`
`deionized
`
`.
`
`:
`
`Method
`
`1. Prepare 5 = ss MOPS buffer by mixing equal volumes of the 0.4 M
`MOPS buffer and Mn?*/isocitrate solution (both supplied with the kit).
`This will slowly oxidize and should be prepared fresh daily.
`2. Mix the following in a microcentrifuge tube:
`e 5ul5 x MOPS
`* 1 wl Primer (0.8 ~M)
`e 14 yl template DNA
`Place in dri-block and heat to 65°C. Keep at this temperature for 2 min,
`then allow to cool slowly by switching off the dri-block. Centrifuge the
`tube to collect any condensation.
`3. Add 4 yl T7 dye terminator mix to the annealed template reactions and
`place in a 37°C heating block for at least 2 min to pre-warm the reaction
`ingredients.
`4. Add 1 «wl of the T7 DNA polymerase (1.5 U), keeping the tube in the
`block and mix well by pumping the pipette carefully several times.
`5. Cover tubes and continue incubation at 37°C for 10 min, then place on
`ice. Spin tubes to collect condensation.
`6. Remove excess dye terminator:
`(a) Biotinylated strand. Place tube in magnetic separator. Remove
`
`169
`
`Page 11 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 11 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`Protocol 3. Continued
`supernatant. Wash DNAon beads two times with 50 p! dye termi-
`nator wash buffer. Wash once with 50 yp! TE and remove wash.
`Keep in the dark.
`(b) Non-biotinylated strand. Precipitate DNA by adding 29.5 pp! 8 M
`ammonium acetate and mix well. Add 150 1! 95% ethanol and place
`on ice in the dark. Spin in a microcentrifuge for 20 min. Remove
`supernatant and dry pellet by heating tube to 90°C for 2 min.
`Resuspend sample in formamide/EDTA by pumping with a pipette. For
`24 lane gel resuspend in 4 pl, for 36 lane gel resuspend in 3 pl. Store
`on ice until gel is ready to be loaded. Electrophorese on the sequencer
`(Protocol 4) using Filter set B.
`
`Protocol 4. Sequencing gel preparation for automatic sequencing
`
`Equipment and reagents
`
`ABI 373A automatic DNA sequencer: ABI
`glass plates, spacers, ge! casting comb,
`lower and upper buffer chambers, heat plate,
`alignment brace, 24- or 36-well sample
`comb, Macintosh computerwith at least 400
`Mb disk capacity
`Distilled or deionized water
`Electrical tape (1.5 inch)
`Urea
`40% acrylamide (frashly prepared)—can be
`bought as 30 g quantities from Bio-Rad
`{19:1
`acrylamide/bisacrylamide), which
`makes 75 mi 40% solution without the need
`for weighing out
`
`Binder clamps
`« Alconox™ (Aldridge)
`Mixed bed resin (Sigma)
`10 = TBE buffer: 0.89 M Tris base, 0.89 M
`boric acid, 0.02 M EDTA
`1 = TBE buffer
`Reusable bottle top filter unit (Nalgene)
`0.5 pm cellulose nitrate membrane filter
`(Whatman)
`Vacuum pump
`10% ammonium persulfate (APS)
`« TEMED
`
`50 mi syringe
`
`
`
`All reagents used should be ultrapure and high grade. Solutions should
`also be filtered to remove any particulate matter that might fluoresce or
`scatter light.
`
`Method
`1. Wash the glass plates, spacers, and comb with Alconox™ and warm
`water. The equipment should then be rinsed thoroughly with warm
`water followed by distilled water. Ethanol or other solvents should
`not be used as these contain fluorescent contaminants. Allow the
`plates to air dry.
`2. Align the plates with spacers between the side and bottom edges and
`then place a clamp on one of the long edges.
`3. Apply electrical tape tightly along the edge opposite the clamp wrap-
`
`170
`
`Page 12 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 12 of 30
`
`

`

`11: Sequence analysis of virus variability based on PCR
`
`ping the tape around both corners. Remove the clamp and then apply
`tape to the second long edge. Finally apply tape along the bottom
`edge. Any air pockets underthe tape should be eliminated and points
`of assembly likely to leak acrylamide solution should be reinforced.
`Particular care should be afforded to the bottom corners.
`
`. For a 60 mi gel solution (enough to pour one gel) mix the following
`reagents:
`e 30 9 urea
`« 9 ml 40% acrylamide stock solution
`e 20 mi distilled water
`e 0.5 g mixed bed resin
`
`. Stir for approximately 1 h until all the urea is dissolved.
`
`. Transfer the acrylamide solution to a 100 mi graduated cylinder con-
`taining 6 mI of filtered 10 = TBE buffer. Adjust the volume to 60 mi
`with distilled water.
`
`. Filter the acrylamide solution through a 0.2 .m cellulose acetate filter
`unit under vacuum, and then degas for 5 min. The degas time should
`be constantfor all gels, to ensure a reproducible polymerization rate
`for all runs.
`
`10.
`
`41.
`
`12.
`
`43.
`
`14.
`
`Gently pour the acrylamide solution into a 150 ml! beaker on ice.
`
`Add 300 »!l 10% ammonium persulfate (freshly made) and 33 ul
`TEMED, and gently swirl avoiding the generation of air bubbles.
`
`Immediately pour the solution between the plates using a 50 ml
`syringe and fill to about 3—5 cm from the top edge of the notched
`plate.
`
`Allow all air bubbles to rise to the surface and then place two clamps
`on either side of the plates.
`
`Insert the gel casting comb and then lay the plates in a horizontal
`position and secure the comb with three clamps. Place the clamps
`directly over the region of the gel casting comb that is sandwiched
`between the glass plates.
`Allow a minimum of 2 h to ensure complete polymerization prior to
`using the gel. The gel may be stored for a maximum of 24 h at room
`temperature although resolution will deteriorate if gels are stored any
`longer.
`Following polymerization remove the clamps, tape, and casting comb
`from the gel. Wash the plates thoroughly with tap-water to remove
`any excess acrylamide on the outside surface, and then rinse with
`distilled water. Ensure that all excess acrylamide is rinsed from the
`top edge of the gel and pay particular attention to the read region of
`the plates.
`
`171
`
`Page 13 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 13 of 30
`
`

`

`Andrew J. Leigh Brown and Peter Simmonds
`
`Protocol 4. Continued
`
`15.
`
`16.
`
`17.
`
`18.
`
`Allow the plates to air dry.
`Switch on the automatic DNA sequencer and open the data collection
`scan and map windows on the Macintosh computer. If the computer
`is networked it is advisable to reboot the computer before a sequence
`run is started.
`Place the lower buffer chamberinto the automatic sequencer and then
`insert the prepared sequencing gel and lock in place. Close thelid of
`the machine.
`Choose ‘Set Up Run’ on the automatic sequencer and verify the electro-
`phoresis conditions. Then choose ‘Configure’ and modify settingsas re-
`quired. Thefilter set for the sequence run can be modified from the
`‘Configure’ options. Filter set A for Taq sequencing and set B for T7
`sequencing.
`Scan the plates to check that they are clean. This can be done using
`the ‘Plate Check’ option from the ‘Start Pre-Run’ menu. If the baseline
`is not flat then clean the plates with distilled water, dry, and re-scan
`until the baselineis flat.
`. Check the PMT setting from the scan window (Y-axis of the lowest
`(typically the blue) line). This should be within the range of 800-1000.
`If outside this range then the PMT maybe adjusted by adjusting the
`PMTvoltage from the ‘Configure’ options on the sequencing machine.
`Conclude the plate check using the ‘Main menu’ option, ‘Abort Run’.
`Place and centre the sharks-tooth comb on the gel surface.
`Assemble the electrophoresis equipment fully and fill the upper and
`lower buffer chambers with 1 x TBE. Rinse the wells with a syringe
`filled with 1 x TBE buffer.
`Load 4 p! formamide/EDTA(for a 24 lane gel) and 3 yl (for a 36 lane
`gel) into the outer lanes on the sequencing gel. Pre-electrophorese
`the gel for 5 min (‘Start Pre-Run’, ‘Pre-Run Gel’).
`Prior to loading, denature the samples by heating at 90°C for 2 min,
`transfer immediately on to ice, and then load on the sequencing gel.
`The samples should be loaded in two batches,first the odd sample
`numbers and then the even. Sample wells should be flushed prior to
`each load with 1 x TBE buffer. The first batch of samples should be
`run for 5 min (‘Start Run’ on the keypad). The run should then be
`interrupted (‘Intrpt Run’) and the second batch of samples loaded and
`ran (‘Resume Run’).
`. Fill out the sample sheet for the sequence run on the Macintosh and
`then commence data collection.
`
`
`19.
`
`24.
`
`172
`
`Page 14 of 30
`
`Supplied by the British Library 13 Mar 2017, 17:37 (GMT)
`
`Page 14 of 30
`
`

`

`11; Sequence analysis of virus variability based on PCR
`
`Sequencing with Tag polymerase (*Taqg-cycle sequencing’) has been de-
`veloped for both manual and automated procedures (Protocol 5). It is the
`most tried and tested procedure with ABI machines and can cope with much
`greater variation in template DNA concentration. However, it is subject to
`greater variability of signal between the four terminating nucleotides. This is
`compensated for by amplification of the signal of the weaker terminators
`within the ABI software, based on the overall level of signal for each. This
`compensation is ‘invisible’ (and inaccessible) to the operator. However, it
`has recently become apparent
`that
`the current version of the software
`assumes an even nucleotide composition, i.e. 25% of each nucleotide in the
`sequence. This is quite satisfactory for many applications, e.g. sequencing of
`mammalian genes, but should the sequence depart significantly from 25%
`base composition then artefacts arise. In the case of HIV, with its very high
`A + T content this presents a particular problem. Specifically, the signal for
`the C terminator is boosted to an inappropriately high level. In consequence
`background C peaks can occasionally be boosted sufficiently to interfere with
`the ‘correct’ peak at a site

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket